Avantel board approves Imeds Global merger and technical director appointment

Management Changes View source PDF Explain this filing

AVANTEL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹136.62

prior close

₹138.04

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.3% vs market

Aerospace & Defense peers, median of 25sector+1.0%-2.9% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 2.9 pts less than its Aerospace & Defense peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.5

10m

-1.6

15m

-1.7

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9+0.4-2.3+1.0-2.9

Next day

-0.1+2.1-2.2+3.2-3.3

-1.6pendingpending+3.0-4.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Aerospace & Defense peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved merging wholly owned Imeds Global into Avantel, pending approvals. FY2026 standalone revenue and net worth were Rs 160.32 lakh and Rs 2,182.83 lakh for Imeds, and Rs 22,135.23 lakh and Rs 35,650.45 lakh for Avantel. No cash payment or share issuance is planned, so ownership stays unchanged. Nimmagadda Sreenivasa Rao, VP Technical, was appointed director for three years from October 26, 2026, pending shareholder approval.

Likely market impact

Ownership is expected to stay unchanged; court and shareholder approvals are pending. The merger may streamline operations and add technical leadership.